Category: $7.3B

  • Roivant Going Public Via MAAC SPAC Merger for ~$7.3B

    Shots: Roivant signs a SPAC merger with MAAC for ~7.3B including $411M in cash in the MAAC trust account and $200M in PIPE stock at $10.00/share. The transaction is expected to deliver ~$611M to fund discovery and development programs and is expected to close in Q3’21 Roivant equity holders and Patient Square Capital have agreed […]